Dr. Leen Kawas has shattered ALL the glass ceilings in her quest to chase the American Dream. As a researcher, inventor and founder of a bioscience company, Leen fueled her passion for change with innovation and tenacity, while raising $400 million to lead her company into a groundbreaking IPO.
Dr. Kawas is the Managing General Partner of Propel Bio Partners. She is the co-founder of Athira and a co-inventor of its lead drug candidate ATH-1017, and also invented several of the innovative drug candidates in Athira’s pipeline. Dr. Kawas served as Athira’s chief executive officer and president, and as a member of its board of directors from January 2014-2021. In this role, she led the technological and financial growth of Athira, raising around $400M and taking the company through its public offering. According to Business Insider and GeekWire, Dr. Kawas was one of only 22 female founders and CEOs to lead their company to an IPO, as of February 2021, and was the first woman to guide a company through an IPO in Washington State in over 20 years (at the time of Athira’s IPO in September 2020).
Join us for this in-depth talk about Dr. Kawas' journey through the IPO process, the need for women at the executive level and why bioscience is so personal for her.
Episode 32: Dr Amy Novotny
Episode 31: Fabienne Fredrickson
Episode 30: Sarah St John
Episode 29: Tracey Sofra
Episode 28: Romana Hasenöhrl
Episode 27: Liz Toombs
Episode 26: Anna Runyan
Episode 25: Dara Rosenbaum
Episode 24: Inbal Claudio
Episode 23: Dannie DeNovo
Episode 22: Mari Anne Snow
Episode 21: Midori Verity
Episode 20: Jeannie Moravits Smith
Episode 19: Carissa McIntyre
Episode 18: Megan Miller
Episode 17: Dana Dickson
Episode 16: Anne Watson
Episode 15: Allie McAllister
Episode 14: Debbie Garner
Episode 13: Chi Chi Okezie
Join Podbean Ads Marketplace and connect with engaged listeners.
Advertise Today
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money